Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2007 2
2008 2
2009 1
2015 2
2017 1
2018 5
2019 3
2020 1
2021 1
2022 3
2023 4
2024 5
2025 10
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital and primary care settings: a retrospective cohort study in infants in Catalonia (Spain).
Coma E, Martinez-Marcos M, Hermosilla E, Mendioroz J, Reñé A, Fina F, Perramon-Malavez A, Prats C, Cereza G, Ciruela P, Pineda V, Antón A, Ricós-Furió G, Soriano-Arandes A, Cabezas C. Coma E, et al. Among authors: mendioroz j. Arch Dis Child. 2024 Aug 16;109(9):736-741. doi: 10.1136/archdischild-2024-327153. Arch Dis Child. 2024. PMID: 38857952 Free PMC article.
Molar-Incisor Hypomineralisation and Allergic March.
Hernandez M, Mendioroz J. Hernandez M, et al. Among authors: mendioroz j. Acta Stomatol Croat. 2020 Jun;54(2):130-135. doi: 10.15644/asc54/2/2. Acta Stomatol Croat. 2020. PMID: 32801371 Free PMC article.
Evolutionary dynamics of HRSV following the implementation of nirsevimab immunoprophylaxis in Catalonia (2023-2024).
González-Sánchez A, Andrés C, Prats-Méndez I, Piñana M, Coma E, Bernet A, Casañ C, Torralba-Calero M, Gutiérrez C, Recio Comí G, Calatayud L, Saubi N, Creus-Costa A, Vila J, Arnedo-Muñoz M, Rando A, Nadal-Baron P, Esperalba J, Balada E, Soriano-Arandes A, Ayats J, Mendioroz J, González-López JJ, Larrosa N, Pumarola T, Martínez-Urtaza J, Antón A. González-Sánchez A, et al. Among authors: mendioroz j. J Infect. 2025 Sep;91(3):106567. doi: 10.1016/j.jinf.2025.106567. Epub 2025 Aug 5. J Infect. 2025. PMID: 40769426 Free article.
Impact of nirsevimab immunoprophylaxis on respiratory syncytial virus-related outcomes in hospital and primary care after two consecutive seasons: a population-based retrospective cohort study in infants in their second year of life in Catalonia, Spain.
Coma E, Martínez-Marcos M, Hermosilla E, Mendioroz J, Reñé A, Fina F, Perramon-Malavez A, Prats C, Antón A, Soriano-Arandes A, Cabezas C. Coma E, et al. Among authors: mendioroz j. Eur J Pediatr. 2025 Sep 13;184(10):616. doi: 10.1007/s00431-025-06440-x. Eur J Pediatr. 2025. PMID: 40946115
Real-world impact of nirsevimab immunisation against respiratory disease on emergency department attendances and admissions among infants: a multinational retrospective analysis.
Perramon-Malavez A, Buonsenso D, Morello R, Coma E, Foster S, Leonard P, Marlow R, Martínez-Marcos M, Mendioroz J, Vila J, Creus-Costa A, Prats C, Roland D, Williams TC, Soriano-Arandes A. Perramon-Malavez A, et al. Among authors: mendioroz j. Lancet Reg Health Eur. 2025 Jun 3;55:101334. doi: 10.1016/j.lanepe.2025.101334. eCollection 2025 Aug. Lancet Reg Health Eur. 2025. PMID: 40950943 Free PMC article.
Unveiling the enterovirus diversity in Barcelona, Spain (2020-2024) through wastewater and clinical surveillance.
Garcia-Pedemonte D, Carcereny A, Andrés C, Antón A, Pérez I, Blanco A, Fuentes C, Costafreda MI, Nadal-Barón P, Galofré B, Paraira M, Mendioroz J, Pintó RM, Bosch A, Guix S. Garcia-Pedemonte D, et al. Among authors: mendioroz j. Emerg Microbes Infect. 2025 Dec;14(1):2589547. doi: 10.1080/22221751.2025.2589547. Epub 2025 Nov 25. Emerg Microbes Infect. 2025. PMID: 41220304 Free PMC article.
Expansion of influenza A(H1N1)pdm09 NA:S247N viruses with reduced susceptibility to oseltamivir, Catalonia, Spain, and in Europe, July to October 2025.
Saubi N, Andrés C, Prats-Méndez I, González-Sánchez A, Davtyan A, Vásquez-Mercado R, Rando A, Nadal P, Esperalba J, Arnedo M, Vicente M, Balada E, Mendioroz J, Martín MC, García-Camuñas K, Vaz R, Najarro A, Bernalte S, Larrosa N, Antón A; SIVIC Infectious diseases sentinel network. Saubi N, et al. Among authors: mendioroz j. Euro Surveill. 2025 Dec;30(48):2500873. doi: 10.2807/1560-7917.ES.2025.30.48.2500873. Euro Surveill. 2025. PMID: 41346317 Free PMC article.
Real-world impact of nirsevimab immunisation and maternal RSV vaccination against respiratory disease on emergency department attendances and admissions: a multinational retrospective analysis.
Perramon-Malavez A, Chiaretti A, Coma E, Craiu M, Foster S, Leonard P, Marlow R, Thors V, Martínez-Marcos M, Mendioroz J, Vila J, Creus-Costa A, Prats C, Roland D, Soriano-Arandes A, Williams TC, Buonsenso D. Perramon-Malavez A, et al. Among authors: mendioroz j. Lancet Reg Health Eur. 2026 Feb 3;63:101597. doi: 10.1016/j.lanepe.2026.101597. eCollection 2026 Apr. Lancet Reg Health Eur. 2026. PMID: 41675439 Free PMC article.
Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023/24 season.
Núñez O, Olmedo C, Moreno-Perez D, Lorusso N, Fernández Martínez S, Pastor Villalba PE, Gutierrez Á, Alonso Garcia M, Latasa P, Sancho R, Mendioroz J, Martinez-Marcos M, Muñoz Platón E, García Rivera MV, Pérez-Martinez O, Álvarez-Gil R, Rivas Wagner E, López Gonzalez-Coviella N, Zornoza M, Barranco MI, Pacheco MDC, Álvarez Río V, Fiol Jaume M, Morey Arance R, Adiego Sancho B, Mendez Diaz M, Batalla N, Andreu C, Castilla J, García Cenoz M, Fernández Ibáñez A, Huerta Huerta M, Ibáñez Pérez AC, Berradre Sáenz B, Lamas J, Hermoso L, Casado Cobo S, Galán Cuesta M, Montenegro S, Domínguez M, Jarrín I, Limia A, Pastor-Barriuso R, Monge S; Nirsevimab Effectiveness Study Collaborators. Núñez O, et al. Among authors: mendioroz j. Euro Surveill. 2025 Feb;30(5):2400596. doi: 10.2807/1560-7917.ES.2025.30.5.2400596. Euro Surveill. 2025. PMID: 39916606 Free PMC article.
47 results